Device manufacturer, as written on reports
Medtronic Minimed: medical device reports filed with FDA
442,554 reports name it as the manufacturer of the device involved, 2002–2026.
- 442,554
- reports naming it as manufacturer
- 1.7% of all MAUDE reports
- 54,842
- reports, 12 months to August 2026
- 62,244 in the 12 months before
- 84.7%
- classified as malfunction
- 62.3% across all reports
- 0.4%
- classified as death, as reported
- 0.9% across all reports
442,554 medical device reports received by FDA give Medtronic Minimed as the manufacturer of the device involved, 1.7% of the MAUDE database, from February 2002 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
54,842 reports arrived in the 12 months to August 2026, down 12% from 62,244 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (84.7%), injury (14.9%) and death (0.4%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Paradigm Real-Time Revel Insulin Infusion Pump | Pump, infusion, insulin, to be used with invasive glucose sensor | 61,173 | 0 | 0.6% |
| Paradigm Real-Time Insulin Infusion Pump | Pump, infusion, insulin, to be used with invasive glucose sensor | 48,973 | 0 | 0.3% |
| Transmitter Mmt-7841zn Gst5g Us | Sensor, glucose, invasive, non-adjunctive | 42,010 | 14,186 | 0% |
| Transmitter Mmt-7841zw Gst5g Ous | Sensor, glucose, invasive, non-adjunctive | 31,568 | 12,351 | 0% |
| Smartphone Android App: Pump Connect | Insulin pump secondary display | 19,765 | 2,720 | 0% |
| Sensor Enlite | Automated insulin dosing , threshold suspend | 17,734 | 0 | 0% |
| Xmtr MMT-7811NA GST3C Lockout | Automated insulin dosing device system, single hormonal control | 16,809 | 65 | 0% |
| Xmtr Mmt-7811xww Gst3c Ous | Automated insulin dosing device system, single hormonal control | 16,132 | 111 | 0% |
| Smartphone iOS App: Pump Connect | Insulin pump secondary display | 14,764 | 1,121 | 0% |
| Guardian Link 3 US | Automated insulin dosing device system, single hormonal control | 11,223 | 229 | 0% |
| Sensor Enlite Mmt-7008a | Automated insulin dosing , threshold suspend | 7,677 | 13 | 0.3% |
| Guardian Link 3 OUS | Automated insulin dosing device system, single hormonal control | 6,662 | 733 | 0% |
| Unknown NGP | Automated insulin dosing device system, single hormonal control | 6,351 | 3,982 | 0.8% |
| Paradigm Insulin Infusion Pump | Pump, infusion, insulin | 6,182 | 0 | 0.4% |
| Sensor Mmt-7040c1 Guardian4 5pk Ous 1 | Automated insulin dosing device system, single hormonal control | 5,635 | 2,007 | 0% |
| Sensor Mmt-7020a Enlite3 5pk Us | Automated insulin dosing device system, single hormonal control | 5,462 | 199 | 0.1% |
| Insulin Infusion Pump | Pump, infusion, insulin, to be used with invasive glucose sensor | 4,997 | 0 | 2.6% |
| Unknown XMTR | Sensor, glucose, invasive | 4,422 | 2,027 | 0% |
| Carelink Personal Mmt-7333 | Sensor, glucose, invasive | 3,513 | 233 | 0% |
| Sensor Mmt-7040a Guardian4 5pk Us | Automated insulin dosing device system, single hormonal control | 3,447 | 2,531 | 0% |
| Reservoir 3ml | Pump, infusion | 2,902 | 0 | 0.8% |
| Sensor Mmt-5120c Instinct 780 5pk Ous 1 | Sensor, glucose, invasive, non-adjunctive | 2,877 | 1,681 | 0% |
| Sensor Mmt-5120d1 Instinct 780 1pk Ous 1 | Sensor, glucose, invasive, non-adjunctive | 2,717 | 1,753 | 0% |
| Sensor Mmt-7020c1 Gs3 5pk 9l Ous1 | Automated insulin dosing device system, single hormonal control | 2,520 | 455 | 0% |
| 530g Insulin Pump | Automated insulin dosing , threshold suspend | 2,245 | 0 | 0.8% |
| Sensor Mmt-7040d1 Guardian4 1pk Ous 1 | Automated insulin dosing device system, single hormonal control | 2,073 | 1,110 | 0% |
| Carelink Connect app iOS | Insulin pump secondary display | 1,855 | 126 | 0% |
| Sensor Mmt-5120d2 Instinct 780 1pk Ous 2 | Sensor, glucose, invasive, non-adjunctive | 1,705 | 1,062 | 0% |
| Sensor Enlite Mmt-7008b | Automated insulin dosing , threshold suspend | 1,665 | 3 | 0% |
| Transmitter Mmt-7841qzw Gst5g Ous Lckout | Sensor, glucose, invasive, non-adjunctive | 1,632 | 187 | 0% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| OYC | Pump, infusion, insulin, to be used with invasive glucose sensor | 126,793 | 28.7% |
| OZP | Automated insulin dosing device system, single hormonal control | 83,481 | 18.9% |
| PQF | Sensor, glucose, invasive, non-adjunctive | 82,929 | 18.7% |
| MDS | Sensor, glucose, invasive | 41,125 | 9.3% |
| PKU | Insulin pump secondary display | 38,038 | 8.6% |
| OZO | Automated insulin dosing , threshold suspend | 30,353 | 6.9% |
| LZG | Pump, infusion, insulin | 21,512 | 4.9% |
| FRN | Pump, infusion | 4,872 | 1.1% |
| SFI | Sensor, glucose, invasive, component of automated insulin delivery system | 4,134 | 0.9% |
| FPA | Set, administration, intravascular | 2,605 | 0.6% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Medtronic Minimed reports
How many FDA device reports name Medtronic Minimed as manufacturer?
442,554 reports through August 2026, 54,842 of them in the latest 12 months.
Which of its brands appear most often?
Paradigm Real-Time Revel Insulin Infusion Pump (61,173), Paradigm Real-Time Insulin Infusion Pump (48,973), Transmitter Mmt-7841zn Gst5g Us (42,010), Transmitter Mmt-7841zw Gst5g Ous (31,568) and Smartphone Android App: Pump Connect (19,765).
Which device types does it report on?
pump, infusion, insulin, to be used with invasive glucose sensor (28.7%), automated insulin dosing device system, single hormonal control (18.9%), sensor, glucose, invasive, non-adjunctive (18.7%) and sensor, glucose, invasive (9.3%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.